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Chalcone is one of the phenolic group secondary metabolic with numerous biological activities. Many 
studies have shown that chalcone derivatives compound has anti-cancer, anti-inflammatory, antimalarial, 
and antibacterial activities. The purpose of this research was to study the prediction potency  
unsaturated carbonyl system of chalcone derivative against HeLa cell by MTT assay. Those activities 
assumed can inhibit the mechanism action of NF-kB that caused cervical cancer. The 2,4-dihydroxide-4’-
methoxychalcone has done synthesis as a target compound by a sonochemical for 7 hours. The results 
showed that chalcone derivative most active against the HeLa cell. 
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1. Introduction 
Cancer is a disease caused by abnormal and uncontrolled cell growth (Anwar et al., 
2018). In its development, cancer cells can spread to other parts of the body and end in 
death. In general, the cause of cancer cannot be ascertained. Various factors both genetic 
and environmental factors (Shanmugam et al., 2016) have a certain contribution to 
increasing the risk of cancer. Various types of cancer, including breast cancer and 
cervical cancer, are contributors to sufficient mortality, tragically, cervical cancer is one 
of the most cancer that diagnosed among woman (Bak et al., 2016), however, new drug 
and new technologies or all-combined have been allowed as solve a problem (Bedell et 
al., 2020). 
Treatment efforts in terms of dealing with cancer certainly continue. Given the 
predicted increase in the surge in cancer patients by 300 percent worldwide in 2030 
with a quantity of 70 percent in developing countries including Indonesia. Based on the 
Ministry of Health data, the prevalence of cancer can reach 4.3 to 1,000 people. For 
2020, about 13,800 new cases of cervical cancer diagnosed in women between 35 until 
44 ages year old and 4,290 women die caused cervical cancer based on The American 
Cancer Society’s estimates. Chalcone as flavonoids classes of plant-derived compounds 
containing than 4000 secondary metabolites (Syed et al., 2016) which several biological 
effects, in recent years, have biochemical and pharmacological as well as anti-cancer 
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(Alper et al., 2019).  Flavonoids as a natural product such as oxorylin A, wogoni, and 
vitexin were reported for the treatment of cancer diseases and undergoing phase I/II 
clinical trials in China (Liu et al., 2020). The conjugation, hydroxylation, and 
substitutions in the chemical structure of chalcone derivates may give significant 
biological activities and flavonoids classes were bearing hydroxyl group and double 
bond of ring recently designed synthesized as biochemical properties as against cancer 
(Hoang et al., 2015). 
Various treatments for many types of cancer, chemotherapy surgery, radiotherapy, 
or combinations, however, multidrug resistance happens in some cases. The 
development of another new drug for design and discovery needs to solve the problem 
(Abbas et al., 2019). Chalcone is an important anti-cancer agent that discovery in the 
synthesized drug-using mechanism of cytotoxic activity of chalcone included by 
apoptosis, cell cycle disruption, inhibition of tubulin polymerization, blockade of nuclear 
factor-kappa B and inhibition of kinases for cervical cancer cell (Abbas et al., 2019).  
Nuclear factor-kappa B (NF-kB) one of the transcription factors as a molecular target 
that critical factors and important studies intervention biological, pharmacological and 
development new drug since they involved in the control of immune responses that 
causes cancer diseases (Kaneko et al., 2019). 
 The aim of the study was to predicted and investigate of the compound that 
obtained by hydroxyl and  unsaturated carbonyl system in chemical structure in 
term of anti-cancer by blockade nuclear factor-kappa B (NF-kB) that the first classical 
pathway (Escárcega et al., 2007) induced genes. This general structure of synthesized is 
shown in Figure 1. and cytotoxic properties shown by the MTT assay data as a cytotoxic 
assay that used directly (Abel & Baird, 2018) to determine cell viability. 
 
2. Material and Method 
 The procedure of synthesis of 2,4-dihydroxide-4’-methoxychalcone using the 
sonochemical method for 7 hours in (Suryani et al., 2019), and all chemicals used 
purified by column chromatography to yield product and purchased commercially. 2,4-
dihydroxide-4’-methoxychalcone characterized by FT-IR, GC-MS, 1H, and 13C-NMR. 
In Vitro anti-cancer, HeLa cells (Luong et al., 2017) (human cervical cancer) in this 
research were culture in Roswell Park Memorial Institute (RPMI) from Parasitology 
Laboratory, Universitas Gadjah Mada. The procedure was started in RPMI, 100 mL of 
cell suspension containing 106 cells was added into microplate 96 each well and 
incubated for 24 h at 37 0C and 5% CO2. A test chalcone compound solution was inserted 
into a cell suspension that had been incubated previously. Added 100 mL of RPMI and 
cancer cells in wells as media and cell control. After the incubation, the culture media 
was removed and washed by PBS, then MTT solution of 100 mL (9.5 mL of RPMI and 1 
mL of MTT solution) was inserted into wells and incubated again for 4 h with the same 
condition. 100 mL of 10% SDS in 0,1 N HCl as stopper reaction added into each of wells. 
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Next, the wells left at room temperature overnight were wrapped by paper tightly. Then, 
absorbance reading by ELISA reader at 595 nm (wavelength optimum) and Percentage 
of survival cells were determined and calculated by eq. 1. 
 
% cell =   100 %..................................................................................................................  (1) 
 
where, 
a =  absorbances of samples  
b =  absorbances of controls media 
c =   absorbances of controls cell 
 
3. Result and Discussion 
3.1. Result 
The compound of 2,4-dihydroxide-4’-methoxychalcone has been synthesized by 
(Suryani et al., 2019) with yield product 98 %, respectively. Sonochemical method using 
to achieve optimal yield and this method an alternative to a short time reaction of 
synthesis. Methanol as a solvent (Figure 1) for synthesis growth a yield as good as 
possible and evaporated easily. The result showed that the sonochemical method was 
efficient (Monsef et al., 2020) since the conventional method needs a long time reaction 
for 24-72 hours. 
 
 
Figure 1. General one-pot synthesis method with reagents; 1) acetophenone, 2) benzaldehyde and 
product; 3) 2,4-dihydroxide-4’-methoxychalcone 
 
Chalcone compound was identified by spectral data IR, EI-MS, 1H, and 13C-NMR 
(Suryani et al., 2019). By 1H-NMR, H  with 7,44 ppm and H  7,86 ppm with doublet 
peak (J = 15 Hz) described the  unsaturated carbonyl of chalcone were performed. 
That peak with chemical shift was specific for  unsaturated carbonyl of chalcone. 
Furthermore the chemical shift of H  presenced downfield since resonance by electron-
withdrawing side with H . 
Hence we assumed that activity in vitro of chalcone against a panel of human 
cervical cell lines (HeLa) by applying 3-(4,5-dimethylthiazol-2-yl)2,5-diphenyl 
tetrazolium bromide (MTT) assay as the most popular assessment of viability and 
cytotoxicity (Pascua-Maestro et al., 2018). Chalcone has an active compound as 
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inhibition of cell growth with IC50 value less than 20 g/mL, moderate active with IC50 
value 20-100 g /mL and not active in the inhibition of cell growth if IC50 value than 100 
g /mL (Anwar et al., 2018). Based on IC50 references, chalcone synthesized has 
moderate activity with IC50 (percentage at which 50% of HeLa cells are dead) value 
shown in Table 1, but that activity of the compound is not selective because of that 
activity against normal cell (Vero) by 42,29 g /mL with the low selectivity index 0,57.   
 
TABLE 1. IC50 values and selectivity index of chalcone 
Compound 
Variation 
of Cons.*  
Viability 
(%) 
IC50 ( g/mL) 
Selectivity 
Index 
















74,24 42,29 0,57 
*Concentration in g/mL 
 
3.2 Discussion 
 Chalcone compound, 2,4-dihydroxide-4’-methoxychalcone was prepared by the 
Claisen-Schmidt according to Scheme 1. To obtain chalcone in good yield, the residues 
were treated with 10 % in methanol. The synthesis compound was evaluated for its 
activity as anti-cancer by showed IC50 value may be influenced to such factors like the 
nature of substitutions in the ring of chalcone, the genetic and biochemical specific 
compound (Solomon & Lee, 2012). 
 Based on Table 1, it showed that the IC50 value chalcone derivative is 74,24 g/mL 
with 0,57g/mL of selectivity index. The IC50 value calculated, represents that the 
concentration of the result in a 50 % decrease in cell growth since the chalcone 
compound is the most widely known as anti-cancer agents. The range as moderate 
activity, the chalcone compound showed as generally better against HeLa cell lines 
cancer.  The addition of the hydroxyl group at positions 2 and 4 in ring A may affect the 
activity cancel line inhibitor, also the methoxy group presence increases inhibitory 
activity too. 
 As a whole, chalcone structure consists of two aromatic rings (A and B) (Han et al., 
2019) with disubstituted of a hydroxyl group in ring A and monosubstituted of methoxy 
in ring B (Mahapatra et al., 2015) have activities moderate level since that substituted 
important as active site (Venkateswararao et al., 2012). Moreover, it was also has a 
double bond opening ring of benzene. Accordingly, the chalcone compound should 
undergo mechanism investigation to understand the active sites as potentially more 
drug agents. Nuclear factor-kB (NF-kB) one of a key role in cancer disease (Folmer et al., 
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2008), then as a subunit of the transcription factor in cancer cells, NF-kB, controlled 
immune responses, proliferation, apoptosis and tumorigenesis (Wu et al., 2019).  
 Investigated of chalcone, particularly that hydroxyl group in the aromatic ring did 
not give a significant activity (Zhang et al., 2018), but  unsaturated carbonyl of 
chalcone predicted inhibiting the activity of transcription activity in an uncontrolled cell 














Figure 2. Predicted interaction  unsaturated carbonyl by Ik-kB at NF-kB transcription 
 
 From Scheme 2,  unsaturated carbonyl of chalcone attacked by Ik-kB, that it 
was IKK protein-mediated of the NF-kB activation pathway (Yadav et al., 2011). Based 
on the mechanism reaction of Scheme 2, bonding between protein Ik-kB and  
unsaturated carbonyl of chalcone may stop NF-kB pathway as caused proliferation of 
cancer cells in humans. As a candidate drug, a mechanism the activity chalcone assumed 
by blocked the NF-kB pathway was identified since the in-vitro MTT assay test. 
 In other particularly research, the hydroxyl group of chalcone as flavonoid 
metabolic secondary, interaction too with Ik-kB of human and it useful to synthesis a 
novel drug (Moulishankar & Lakshmanan, 2020). When we treat cancer cases, activation 
of NF-kB should be blocked and the Ik-kB activation pathway did not bind with NF-kB 
when  unsaturated carbonyl bind with Ik-kB than NF-kB transcription factor will be 
inhibited (Yoon & Rui, 2007). Despite chalcone effects, it potency (Meng et al., 2014), the 
active site for inhibited NF-kB was an important role in determining chalcone to docking 
molecular as an anti-cancer drug in future (Ren et al., 2017). To rapidly, when the 
compound of drug identify inhibiting the NF-kB signaling pathway currently these drugs 
provide have development.  
  
Conclusion 
 Briefly, Chalcone derivative was synthesized successfully by the sonochemical 
method, and presence yields 98 % with IC50 value 74,24 g/mL. The biological activity 
was studied, from data can be seen that the IC50 value of chalcone has a moderate 
activity towards cervical (HeLa) cancer cell lines. According to the IC50 and selectivity 
index value, it can be indicated that chalcone derivative against a cervical cancer cell line 
may affect since  unsaturated carbonyl of chalcone and that assumed as the active 
sites for inhibiting growth cancer line by binding with Ik-kB protein then blocked NF-kB 
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pathway activation as caused cancer growth. This suggests that chalcone derivative is a 
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